Home
Conditions
Leukemia, Myeloid

Clinical trial condition

Leukemia, Myeloid

Explore clinical trials studying Leukemia, Myeloid. Study availability and eligibility vary by location and protocol.

3,108 public trials 620 recruiting studies

Refine in advanced search Browse all conditions

Leukemia, Myeloid trial results

Completed

Donor Peripheral Stem Cell Transplant in Treating Patients With Hematolymphoid Malignancies

NCT01523223

Conditions: Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), +82 more
Locations: Stanford University Stanford, California, United States

View Trial Details

Completed

Study of a Novel BET Inhibitor FT-1101 in Patients With Relapsed or Refractory Hematologic Malignancies

NCT02543879

Conditions: Acute Myelogenous Leukemia, Acute Myeloid Leukemia, Bone Marrow Diseases, +16 more
Locations: Cedars Sinai Los Angeles, California, United States

Florida Cancer Specialists Sarasota, Florida, United States

Moffitt Cancer Center Tampa, Florida, United States

Northwestern University Chicago, Illinois, United States

View Trial Details

Completed

Phase II Trial in Elderly Patients With AML or MDS in Complete Remission Not Eligible for Allogenic Transplant

NCT03961919

Conditions: Acute Myeloid Leukemia, Bone Marrow Diseases, Hematologic Diseases, +8 more
Locations: Ospedale San Raffaele Milan, Lombardy, Italy

View Trial Details

Completed

Ph I Study of Alvocidib and Cytarabine/Daunorubicin (7+3) in Patients With Newly Diagnosed Acute Myeloid Leukemia (AML).

NCT03298984

Conditions: Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: Sidney Kimmel Cancer Center at Johns Hopkins Baltimore, Maryland, United States

Columbia University New York, United States

University of North Carolina Chapel Hill, North Carolina, United States

View Trial Details

Completed

A Study of BBI608 in Adult Patients With Advanced, Refractory Hematologic Malignancies

NCT02352558

Conditions: Blood Protein Disorders, Bone Marrow Diseases, Cardiovascular Diseases, +30 more
Locations: Rocky Mountain Cancer Centers Denver, Colorado, United States

Indiana University Indianapolis, Indiana, United States

West Clinic Germantown, Tennessee, United States

Cancer Care Centers of South Texas San Antonio, Texas, United States

View Trial Details

Completed

A Study of DSP-7888 Dosing Emulsion in Adult Patients With Advanced Malignancies

NCT02498665

Conditions: Acute Myeloid Leukemia, Adenocarcinoma, Adnexal Diseases, +67 more
Locations: USOR - Rocky Mountain Cancer Center Denver, Colorado, United States

Emory University Winship Cancer Institute Atlanta, Georgia, United States

Horizon Oncology Research Lafayette, Indiana, United States

USOR - TX Oncology Austin Austin, Texas, United States

View Trial Details

Completed

Safety and Efficacy of BL-8040 for the Mobilization of Donor Hematopoietic Stem Cells and Allogeneic Transplantation in Patients With Advanced Hematological Malignancies

NCT02639559

Conditions: Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Blood Protein Disorders, +38 more
Locations: Northside Hospital Cancer Institute Atlanta, Georgia, United States

Washington University School of Medicine St Louis, Missouri, United States

Ohio State University Columbus, Ohio, United States

View Trial Details

Completed

Stem Cell Transplant for Juvenile Myelomonocytic Leukemia (JMML)

NCT00167219

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +7 more
Locations: Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States

View Trial Details

Completed

Donor Natural Killer Cells and Donor Stem Cell Transplant in Treating Patients With High Risk Myeloid Malignancies

NCT01823198

Conditions: Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Erythroid Leukemia, Acute Megakaryoblastic Leukemia, +36 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Study of Milademetan in Japanese Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML)

NCT03671564

Conditions: Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: Japanese Red Cross Narita Hospital Chiba, Japan

Kyusyu University Hospital Fukuoka, Japan

Gifu Municipal Hospital Gifu, Japan

Chugoku Central Hospital Hiroshima, Japan

View Trial Details

Leukemia, Myeloid

Leukemia, Myeloid trial results

Related conditions